Why FTSE 100 shares Persimmon and AstraZeneca may still offer value for money
Robert Stephens, CFA, discusses the prospects for Persimmon and AstraZeneca
3 years ago
Latest
Hybridan Small Cap Feast
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.
3 years ago
The best and worst performing funds of 2021
Nick Sudbury runs through the 2021's top picks and some funds that you would have been better off avoiding.
3 years ago
Small-cap comment featuring BMS, ALU, SNWS and FLO
Mark Watson-Mitchell updates his readers on previous company profiles and other news of interest from the exciting world of small-cap…
3 years ago
Hybridan Small Cap Feast
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.
3 years ago
Inland Homes – profit upgrades expected with the figures later this month
Mark Watson-Mitchell opens 2022 with a look at this housebuilder ahead of its 2021 final results.
3 years ago
What Investors Need to Know about 2022 – Part I – the UK
In 2022, in financial markets and in UK politics, the fundamental principle that risk management trumps risk aversion will be…
3 years ago
Don’t get sucked in by the New Year tips
Whatever you do, please do not get sucked into any of the media ‘end-of-the-year’ share tips – unless you have…
3 years ago
Evil Diaries: Different expressions of intangibility
Simon Cawkwell, AKA Evil Knievil, with his latest trading and gambling exploits – writing exclusively for Master Investor.
3 years ago
Do Vodafone and Legal & General’s high yields appeal as inflation soars to a 10-year high?
Robert Stephens, CFA, discusses the prospects for two FTSE 100 income shares.
3 years ago